Skip to content
← Full study record

NCT05105087 · OUTCOME

Size of Sentinel Lymph Nodes (SLNs) Identified

Gynecological Sentinel Lymph Nodes CEUS · Source last updated 2025-08-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
centimeters (cm)
Interval / dispersion
Full Range
Time frame
up to 30 minutes during CEUS procedure

What was measured

The locations, depth beneath the skin surface and size (measured in three orthogonal dimensions) of each SLN will be recorded.

Analysis population: Only participants who completed CEUS and surgery (N=5) were analyzed.

Groups in this outcome

Diagnostic (Perflubutane Microbubble, Ultrasound)

Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment. Perflubutane Microbubble: Given subdermally Contrast-Enhanced Ultrasound: Undergo ultrasound

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diagnostic (Perflubutane Microbubble, Ultrasound)5

Analysis denominator · sentinel lymph nodes (SLNs)

GroupSource count
Diagnostic (Perflubutane Microbubble, Ultrasound)17

Reported measurements

Source class 1
Values in centimeters (cm) · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Diagnostic (Perflubutane Microbubble, Ultrasound)1.6Not reported0.72.4Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.7
        upper Limit
        2.4
        value
        1.6
denom Units Selected
sentinel lymph nodes (SLNs)
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    units
    Participants
  2. counts
    1. group Id
      OG000
      value
      17
    units
    sentinel lymph nodes (SLNs)
description
The locations, depth beneath the skin surface and size (measured in three orthogonal dimensions) of each SLN will be recorded.
dispersion Type
Full Range
groups
  1. description
    Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment. Perflubutane Microbubble: Given subdermally Contrast-Enhanced Ultrasound: Undergo ultrasound
    id
    OG000
    title
    Diagnostic (Perflubutane Microbubble, Ultrasound)
param Type
MEAN
population Description
Only participants who completed CEUS and surgery (N=5) were analyzed.
reporting Status
POSTED
time Frame
up to 30 minutes during CEUS procedure
title
Size of Sentinel Lymph Nodes (SLNs) Identified
type
SECONDARY
type Units Analyzed
sentinel lymph nodes (SLNs)
unit Of Measure
centimeters (cm)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice